Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01318109
What this trial is testing

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 288
Early research (Phase 1)Ended earlyNCT03332836
What this trial is testing

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 21
Large-scale testing (Phase 3)Study completedNCT00838916
What this trial is testing

Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 779
Not applicableTemporarily pausedNCT03921216
What this trial is testing

Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

Who this might be right for
Diabetes Mellitus, Type 2Diabetic NephropathiesChronic Kidney Diseases
Karolinska University Hospital 20
Early research (Phase 1)Study completedNCT07266779
What this trial is testing

Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.

Who this might be right for
Type 2 Diabetes
Humanis Saglık Anonim Sirketi 36
Large-scale testing (Phase 3)Study completedNCT04795531
What this trial is testing

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 588
Not applicableStudy completedNCT04383639
What this trial is testing

Cocoa/Carob Polyphenols and Postprandial Changes in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
National Research Council, Spain 20
Early research (Phase 1)Ended earlyNCT01923389
What this trial is testing

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT00998699
What this trial is testing

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
XOMA (US) LLC 22
Early research (Phase 1)Study completedNCT02759107
What this trial is testing

Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Who this might be right for
HealthyType 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company 142
Large-scale testing (Phase 3)Looking for participantsNCT07394114
What this trial is testing

HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 240
Early research (Phase 1)Study completedNCT01794364
What this trial is testing

Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

Who this might be right for
Healthy
Pfizer 8
Not applicableStudy completedNCT02346344
What this trial is testing

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Foundation for the National Institutes of Health 20
Very early researchStudy completedNCT02317211
What this trial is testing

Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus，Type 2
Sun Yat-sen University 70
Large-scale testing (Phase 3)Study completedNCT01381900
What this trial is testing

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 678
Large-scale testing (Phase 3)Ended earlyNCT00203632
What this trial is testing

Glitazones and Endothelial Function (GATE)

Who this might be right for
Diabetes Mellitus
University of Calgary 40
Large-scale testing (Phase 3)Study completedNCT01494987
What this trial is testing

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 431
Large-scale testing (Phase 3)Study completedNCT02128932
What this trial is testing

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,089
Large-scale testing (Phase 3)Study completedNCT00225264
What this trial is testing

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

Who this might be right for
Diabetes Mellitus
Takeda 458
Not applicableStudy completedNCT01278485
What this trial is testing

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 726
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation